Hofseth Biocare sees “accelerating sales mix” in Q1 despite COVID-19 disruptions

Related Articles

FormattedPicture

FOOD RESEARCH

The nutraceutical ingredient could help to reduce lung inflammation, restore respiratory health and reduce lung scarring caused by eosinophilic asthma, a new study... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

A “trailblazing” Stanford University study has underlined the positive effects of Hofseth BioCare’s (HBC) nutraceutical ingredient ProGo for restoring... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As consumers become increasingly knowledgeable about the ingredients they seek out in their supplements, industry must now be better prepared for transparency.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Norwegian-based Hofseth BioCare (HBC) ASA received New Dietary Ingredient (NDI) acknowledgment from the US Food and Drug Administration (FDA) for its bioactive peptide... Read More

FormattedPicture

BUSINESS NEWS

In nutrition news this week, RedLeaf received US$485,000 in funding from the Kentucky Agricultural Development Board for regional agricultural expansion. A study... Read More

trans